Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash and Cash Equivalents	$ 746,931	$ 1,385,275
Restricted Cash	138,118	142,688
Accounts Receivable, Net	146,696	492,752
Inventory, Net	576,190	344,654
Other Current Assets	186,355	310,657
Total Current Assets	1,794,290	2,676,026
PROPERTY AND EQUIPMENT, NET	37,705	38,189
OTHER ASSETS
Intangible Assets, Net
Other Assets	256,547	273,419
Total Other Assets	256,547	273,419
Total Assets	2,088,543	2,987,634
CURRENT LIABILITIES
Accounts and Other Payables	2,991,729	2,955,826
Due to Related Parties	300,000	300,000
Short Term Debt	224,648	50,000
Current Portion of Long-Term Debt	116,432	120,284
Total Current Liabilities	3,632,809	3,426,110
LONG-TERM DEBT	298,843	338,803
LONG-TERM DIVIDENDS PAYABLE
STOCKHOLDERS’ EQUITY
Preferred Stock, $0.00001 par value; 12,500,000 shares authorized Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively
Common Stock, $0.00001 par value; 37,500,000 shares authorized; 11,561,647 and 9,668,369, shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	116	97
Additional Paid-In Capital	47,724,107	40,727,518
Subscription Receivable	(7,370,350)
Accumulated Comprehensive Loss	(168,783)	(143,493)
Accumulated Deficit	(42,028,199)	(41,361,401)
Total Stockholders’ Equity (Deficit)	(1,843,109)	(777,279)
Total Liabilities and Stockholders’ Equity	$ 2,088,543	$ 2,987,634